XML 52 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financial Instruments and Derivatives Instruments (Tables)
 3 Months Ended
Apr. 01, 2012
Financial Instruments and Derivatives Instruments  
Schedule of fair value of financial assets and liabilities

Fair Value Measurements at April 1, 2012 Using:

 

 

 

 

 

Quoted Prices in
Active
Markets for Identical
Assets

 

Significant Other
Observable
Inputs

 

Significant
Unobservable
Inputs

 

 

 

Total

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

(in millions)

 

Assets

 

 

 

 

 

 

 

 

 

Plan asset for deferred compensation(1)

 

$

4.4

 

$

4.4

 

$

—

 

$

—

 

Total assets

 

$

4.4

 

$

4.4

 

$

—

 

$

—

 

Liabilities

 

 

 

 

 

 

 

 

 

Plan liability for deferred compensation(2)

 

$

4.4

 

$

4.4

 

$

—

 

$

—

 

Contingent consideration(3)

 

6.2

 

—

 

—

 

6.2

 

Total liabilities

 

$

10.6

 

$

4.4

 

$

—

 

$

6.2

 

 

 

 

 

Fair Value Measurements at December 31, 2011 Using:

 

 

 

 

 

Quoted Prices in Active
Markets for Identical Assets

 

Significant Other
Observable
Inputs

 

Significant
Unobservable
Inputs

 

 

 

Total

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

(in millions)

 

Assets

 

 

 

 

 

 

 

 

 

Plan asset for deferred compensation(1)

 

$

4.0

 

$

4.0

 

$

—

 

$

—

 

Total assets

 

$

4.0

 

$

4.0

 

$

—

 

$

—

 

Liabilities

 

 

 

 

 

 

 

 

 

Plan liability for deferred compensation(2)

 

$

4.0

 

$

4.0

 

$

—

 

$

—

 

Contingent consideration(3)

 

1.1

 

—

 

—

 

1.1

 

Total liabilities

 

$

5.1

 

$

4.0

 

$

—

 

$

1.1

 

 

 

(1)          Included in other, net on the Company’s consolidated balance sheet.

(2)          Included in accrued compensation and benefits on the Company’s consolidated balance sheet.

(3)          Included in other non-current liabilities and accrued expenses on the Company’s consolidated balance sheet.
Summary of the changes in fair value of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3)

 

 

 

 

Balance

 

Purchases,

 

Total realized and
unrealized gains
(losses) included in:

 

Balance

 

 

 

December 31,

 

sales,

 

 

 

Comprehensive

 

April 1,

 

 

 

2011

 

settlements, net

 

Earnings

 

income

 

2012

 

 

 

(in millions)

 

Contingent consideration

 

$

1.1

 

$

5.1

 

$

—

 

$

—

 

$

6.2

 
Carrying amount and estimated fair market value of the company's long-term debt, including current portion

 

 

 

 

April 1,

 

December 31,

 

 

 

2012

 

2011

 

 

 

(in millions)

 

Carrying amount

 

$

395.6

 

$

399.4

 

Estimated fair value

 

$

434.6

 

$

440.5